Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets open firm
Fri, 12 Aug 09:30 am

Asian stock markets have opened the day on a firm note. Stock markets in Hong Kong (up 1.6%), South Korea (up 1%), Japan (up 0.2%), China (up 0.6%) and Indonesia (up 1.4%) are trading in the green. The Indian stock markets have opened the day on a positive note as well. Stocks in the Realty and Consumer Durables space are leading the gains.

The BSE-Sensex is trading up by 60 points (0.4%) and the NSE-Nifty is up by around 19 points (0.4%). Midcap and small cap stocks are trading in the green as well, with the BSE Midcap and BSE Small cap indices up by 1% and 0.9% respectively. The rupee is trading at 45.30 to the US dollar.

Pharma stocks have opened the day on a mixed note with Pfizer and GSK Pharma in the red while Merck in the green. The final hearings for the landmark Novartis case have commenced at the Supreme Court. The case is regarding Novartis' blood cancer drug Glivec for which the company was denied the patent. This would be a landmark judgment as it would have huge implications on the interpretation and implementation of the new Indian Patents Acts. The final hearing would last through the next few days according to the lawyers familiar with the case. Novartis said to the court that Glivec is entitled to a patent in India due to the novelty of the drug which has shown better efficacy. If the patent is granted, Novartis will be able to sell the product exclusively for 20 years.

Oil & gas stocks have opened the day on a mixed note as well with Cairn and Petronet in the green while Reliance Industries (RIL) in the red. Castrol India has announced its second quarter results for the calendar year 2011 (2QCY11). The company's net sales have gone up by 6% YoY to Rs 7.9 bn during the quarter. Operating profits declined by 14% YoY to about Rs 2 bn on account of adverse base oil prices and additive cost scenario. As a result, operating margins dropped from 30.2% in 2QCY10 to 24.8% in 2QCY11. At the bottomline level, profits declined by 5% YoY to Rs 1.4 bn. Net profit margin declined to 18% during the quarter against 20.2% in the corresponding quarter of the previous financial year. The company's board has declared an interim dividend of Rs 7 per share for the year ending December, 2011.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.